Delivery Order SPE2DB22D1106-SPE2DB25FEUV9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,719.34 to AmerisourceBergen Drug Corp for PREVYMIS 480 MG tablets (7-count packages) with an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a child contract action under AmerisourceBergen's broader relationship with the federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of PREVYMIS 480 mg tablets (14-count) under a firm fixed-price contract valued at $2,372.90. The delivery order, classified as a child contract, is scheduled for completion by October 2, 2025, with performance taking place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation. This...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of PREVYMIS 480 MG tablets in a quantity of 7 units, valued at $9,438.70. This is a firm fixed price delivery order issued on July 22, 2025, with an ultimate completion date of August 12, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, and the place of performance...
- The Defense Logistics Agency awarded a $10,512.10 delivery order to AmerisourceBergen Drug Corp on January 16, 2026, for the supply of Prevymis 480 mg tablets (quantity: 7 units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of February 9, 2026. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s...
- The Defense Logistics Agency awarded a delivery order valued at $15,768.15 to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of PREVYMIS 480 mg tablets in packages of seven. This firm fixed-price delivery order has an ultimate completion date of February 3, 2026, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award was not set aside for any particular business category, indicating it was competitively awarded on a full and open basis....
- The Defense Logistics Agency awarded a $5,256.05 delivery order to AmerisourceBergen Drug Corp on January 15, 2026, for the supply of Prevymis 480 mg tablets (7-count packaging) under a firm fixed-price contract type. The award is non-set-aside and competitively awarded, with an ultimate completion date of February 6, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location. This...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,719.34 by the Defense Logistics Agency on July 31, 2025, for the supply of Prevymis 480 mg tablets in packages of seven units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 21, 2025, and represents performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The award is a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency for $4,973.46 to supply Prevymis 480 mg tablets (7-count packages) with a firm fixed price. The award, issued on November 28, 2025, is scheduled for completion by December 19, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $4,719.34 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Prevymis 480 mg tablets in quantities of seven per unit. This non-set-aside competitive award will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with a completion date of November 21, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor,...
- This contract award represents a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Prevymis (480 mg tablets, 7-count packages) with a ceiling value of $10,512.10. The award was made on January 13, 2026, with an ultimate completion date of February 4, 2026, and utilizes firm fixed-price pricing with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEUV9Delivery Order
The Defense Logistics Agency awarded a $18.88K delivery order to AmerisourceBergen Drug Corp on June 24, 2025, for the supply of PREVYMIS 480 mg tablets (seven-count packaging). This is a competitively awarded, firm fixed-price contract with no set-aside designation, with performance to be completed by July 16, 2025, and fulfillment based in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical commodities to military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to fulfill diverse pharmaceutical supply requirements across multiple therapeutic domains, ranging from specialty medications and vaccines to medical devices and supplies. This award of PREVYMIS—an antiviral medication used in transplant medicine—exemplifies the company's role in supporting Defense Health Agency medical supply needs through competitive procurement mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.9k | 6/24/25 |